Autres langues Cipla Limited

Actions

CIPLA

INE059A01026

Produits pharmaceutiques

Marché Fermé - NSE India S.E. Autres places de cotation 13:05:07 10/07/2026			Varia. 5j.	Varia. 1 janv.
1 439,40 ^INR	-0,13%		-1,29%	-4,76%

07/07	Inde : les boutiques de l'aéroport de Mumbai du groupe Adani accusées de vente illégale de sachets de nicotine	RE
24/06	CIPLA LIMITED : Avendus Spark reste à l'achat	ZM

Autres langues

07/07	India finds Adani's Mumbai airport shops sold nicotine pouches in breach of law
16/06	Cipla Limited Appoints Shivam Puri as Chief Executive Officer of Its One India Business, Effective July 1, 2026
15/06	Global drugmakers invest billions to boost US presence
12/06	India raises price cap on cancer drugs to tackle shortage
11/06	Cipla's Goa, India Facility Receives VAI Status from US FDA
09/06	Indian cancer patients battle shortage of key drugs as platinum costs surge
22/05	India's Sun Pharma posts profit beat on specialty drug demand, shares slide on cost pressures
14/05	Cipla Limited announces Annual dividend, payable on July 25, 2026
13/05	Cipla Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
13/05	Indian drugmaker Cipla misses Q4 profit view on weak US sales
13/05	Cipla Q4 consol net profit 5.55 billion rupees
13/05	Cipla Limited Appoints Sushrut Kulkarni as President & Global Chief - Integrated Product Development, Effective from May 18, 2026
13/05	Indian drugmaker Cipla's fourth-quarter profit misses view on weak US sales
06/05	Cipla Limited Launches Ciposcillo Advanced Oscillometer for Respiratory Diagnostics
28/04	Pfizer secures deals to keep heart drug free of generic rivals until 2031
28/04	Pfizer reaches settlement agreements with Dexcel Pharma, Hikma & Cipla for Vyndamax
28/04	Pfizer Settles With Three Drug Manufacturers Over Alleged Patent Infringement
24/04	Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin HFA
23/04	Cipla Limited Announces U.S. Fda Approval for First Ab-Rated Generic of Ventolin Hfa
23/04	Indian Equities Extend Losses on Thursday as Banking Sell-Off, Crude Oil Surge Weigh
23/04	Cipla Arm Gets US FDA's Final Nod for Albuterol Sulfate Inhalation Aerosol; Shares Up 3%
23/04	Cipla receives US FDA approval for first AB-rated generic of Ventolin HFA
17/04	Cipla's manufacturing facility in Goa undergoes US FDA inspection
15/04	Tejas Networks Limited Announces Resignation of P R Ramesh as Independent Director, Effective on April 18, 2026 and Appointment of Preetham Uthaiah as Chief Operating Officer, Effective April 15, 2026
03/04	Cipla expands U.S. respiratory portfolio with approval of nintedanib capsules (100mg & 150mg) for idiopathic pulmonary fibrosis